Company profile for Summit Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our vision is to be recognized as the leader in the field of intranasal pharmaceutical drug products development and manufacturing. We intend to accomplish this by applying our unique formulation and manufacturing expertise and by leveraging our state-of-the-art cGMP manufacturing facility and our high-speed nasal products manufacturing and packaging equipment to address a high-growth, niche market. Our Facilities: Our headqua...
Our vision is to be recognized as the leader in the field of intranasal pharmaceutical drug products development and manufacturing. We intend to accomplish this by applying our unique formulation and manufacturing expertise and by leveraging our state-of-the-art cGMP manufacturing facility and our high-speed nasal products manufacturing and packaging equipment to address a high-growth, niche market. Our Facilities: Our headquarters and FDA approved manufacturing plant are located in Lexington, Kentucky on the University of Kentucky’s Coldstream Research Campus. Our facility contains a cGMP laboratory, cGMP manufacturing and warehousing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1513 Bull Lea Rd, Lexington, KY 40511, USA
Telephone
Telephone
859-254-0180
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/akeso-summit-pd-1xvegf-meets-overall-survival-goal-first-time-lung-cancer-trial

FIERCE PHARMA
27 Aug 2025

https://www.fiercepharma.com/pharma/akeso-summits-ivonescimab-delayed-progression-48-certain-lung-cancers-first-global-phase-3

FIERCE PHARMA
30 May 2025

https://www.biospace.com/drug-development/summit-declares-nsclc-victory-over-keytruda-analysts-advise-caution-with-china-only-data

BIOSPACE
10 Sep 2024

https://www.businesswire.com/news/home/20240117554516/en

BUSINESSWIRE
18 Jan 2024

https://www.globenewswire.com/news-release/2020/05/28/2040298/0/en/Atossa-Therapeutics-Announces-Second-COVID-19-Therapeutic-Development-Program-AT-301-Nasal-Spray-Summit-Biosciences-Retained-to-Develop-and-Supply-AT-301-Nasal-Spray-for-Clinical-S.html

GLOBENEWSWIRE
28 May 2020

https://www.fiercebiotech.com/biotech/summit-therapeutics-tops-up-c-diff-war-chest-8-8m-barda-funding

A. Al Idrus FIERCE BIOTECH
24 Jan 2020

Services

Upload your portfolio for free, ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty